Evidence map›Paper›PMID 33574052›Full record

ArticleThe European respiratory journal2021

The case of methotrexate and the lung: Dr Jekyll and Mr Hyde.

Vincent Cottin, Elizabeth Bendstrup, Philippe Bonniaud, Mouhamad Nasser, Paolo Spagnolo, Claudia Valenzuela, Martin Kolb

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Methotrexate-Induced Pneumonitis in a Patient with Chronic Chikungunya Arthritis.Revista da Sociedade Brasileira de Medicina Tropical · 2025
    Article
  6. Flashy lungs and sarcoidosis: not always a sign of disease activity.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2024
    Article
  7. Relative incidence of interstitial lung diseases in Brazil.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Vincent CottinDept of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0002-5591-0955
Elizabeth BendstrupCenter for Rare Lung Diseases, Dept of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0002-4238-6963
Philippe BonniaudConstitutive Reference Center for Rare Pulmonary Diseases, Dept of Pulmonary Medicine and Intensive Care Unit, University Hospital, Bourgogne-Franche-Comté, Burgundy University, Inserm 1231, Dijon, France.
Mouhamad NasserDept of Respiratory Medicine, National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Lyon, France.ORCID 0000-0001-8373-8032
Paolo SpagnoloRespiratory Disease Unit, Dept of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Claudia ValenzuelaPulmonology Dept, Hospital Universitario de la Princesa, Universidad Autonoma de Madrid, Madrid, Spain.ORCID 0000-0002-0856-6290
Martin KolbDept of Respiratory Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-3837-1467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LungMethotrexateHumansMethotrexate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.